A team of researchers from HSE University, the Russian Academy of Sciences Zelinsky Institute of Organic Chemistry, and Molecular Technologies, LLC have jointly proposed a new treatment for osteoarthritis. This is currently the first disease-modifying osteoarthritis drug to act simultaneously on bone and cartilage tissue metabolism and on inflammation. The study findings are published in
Scientific Reports.